| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought 2 open-market purchases by 2 insiders worth about $6K and no sales. The 12 months before that brought 7 open-market purchases by 4 insiders worth about $84K and no sales.
The largest open-market purchase in the last two years was 35,000 shares by Kenneth Van Heel (Director) at an average $0.88 on August 27, 2025, about $31K. Twelve months later ICU was down 63%.
The most recent purchase was by Jennifer A Baird (Director) on December 19, 2025.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 50.1K | $100.3K | - | |
| Other | 20.8K | $41.6K | - | |
| CFO | 17.5K | $35.0K | - | |
| Dir | 12.2K | $24.4K | - | |
| Dir | 11.9K | $23.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Jennifer A Baird | Director | Buy | 4,200 | $0.24 | $987.42 | +13.1% | -7.3% | - | |
| Dec 9, 2025 | Michael Messinger | Chief Financial Officer | Buy | 14,500 | $0.35 | $5,098.20 | +483.3% | -25.9% | - | |
| Aug 27, 2025 | Kenneth Van Heel | Director | Buy | 35,000 | $0.88 | $30,812.50 | +243.1% | -62.5% | -63.4% | |
| Aug 22, 2025 | Kevin Chung | Chief Medical Officer | Buy | 10,000 | $0.80 | $8,000.00 | +20.8% | -61.3% | -58.1% | |
| Jun 30, 2025 | Jennifer A Baird | Director | Buy | 10,000 | $0.42 | $4,174.00 | +55.6% | +40.9% | -13.8% | |
| Jun 24, 2025 | John Neuman | Director | Buy | 40,000 | $0.36 | $14,396.00 | +100.0% | +178.1% | -14.1% | |
| May 20, 2025 | Jennifer A Baird | Director | Buy | 10,000 | $1.28 | $12,815.00 | New | -35.4% | -69.1% | |
| May 20, 2025 | Kevin Chung | Chief Medical Officer | Buy | 4,500 | $1.25 | $5,625.00 | +32.9% | -35.4% | -69.1% | |
| Dec 11, 2024 | John Neuman | Director | Buy | 40,000 | $3.83 | $153,227.00 | New | -7.7% | -83.7% | |
| Nov 18, 2024 | Kevin Chung | Chief Medical Officer | Buy | 4,250 | $1.99 | $8,457.50 | +45.0% | -17.3% | -85.1% |